Bayer Schering Pharma

Bayer HealthCare Investor Day - Tuesday June 19. 2007

Tue, Jun 19, 2007 06:00 CET

This will happen today:Welcome and introduction by Werner Wenning, CEO of Bayer AG. Presentations by Bayer HealthCare Management.Topics include the integration of Schering, product and R&D strategy, and comprehensive updates on the Bayer Schering Pharma pipeline and the Consumer Health businessAt 7.00 am CEST- Investor news published- Presentation charts for download under: www.investor.bayer.com- Bayer HealthCare press information (release, backgrounder on divisions, fact sheets on pipeline projects, CVs, photographs) available on: www.investorday2007.bayerhealthcare.com- New R&

Invitation to webcast ‘Benefit from Time’ - Panel Discussion from XVIIIth World Congress of Neurology

Fri, Nov 11, 2005 10:04 CET

Welcome to follow a webcast of world leading experts discussing new data for Betaferon® and its potential implications for Multiple Sclerosis (MS) treatment. Just go to www.benefitfromtime.com and follow the instructions.WHY: Betaferon® has been on the market for 16 years and has been proven to be an effective and well-tolerated therapy for relapsing forms of MS. Trial were presented that point to a possible advance in the way that patients at risk of MS are treated, through early intervention. We have assembled a panel of experts from around the world to discuss this data and its

Share

Bayer HealthCare Investor Day - Tuesday June 19. 2007

Invitation to webcast ‘Benefit from Time’ - Panel Discussion from XVIIIth World Congress of Neurology